Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, many drugs have been explored for repurposing against severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). While several have unfortunately led to a lack of results, plenty show promise. In a review published in Emerging Microbes & Infections, researchers from Sorbonne Université have been reviewing papers exploring different anti-COVID-19 drugs.
The review
The researchers reviewed papers examining COVID-19 between January 2020 and August 2021. They identified several virus-centered strategies, including using antivirals to prevent aggravation of clinical patients with mild symptoms or to limit the propagation of the virus.
